🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣Whether you're treating #AFib or just trying to stay on top of the latest, join Dr. Jose Joglar & Prof. Gregory Lip as they break down the latest U.S. and European guidelines 👇👇👇 tinyurl.com/2h5t4djz Vasculearn Network Liverpool Centre for Cardiovascular Science Jacopo Imberti Francesco Vitali Luca Bergamaschi

#AcuteCVDays week 5 recap💪 Check out the amazing resources prepared by Jacopo Imberti & Anna Oleksiak, MD PhD, including podcasts, webinars & publications on the most innovative approaches to acute #Stroke Treatment 🖇️tinyurl.com/5ksmh79n ACVCPresident European Society of Cardiology

🆕study in Asia shows #AFib females have a higher #stroke risk than males only in high CHA2DS2-VA score categories. What was seen in European data may not reflect all populations globally! 🔗 tinyurl.com/4acf4u9u Liverpool Centre for Cardiovascular Science HeartRhythm

🚨Lights and shadows about the OPTION trial Check out our latest #ESCStrokeBlog by Marco Micillo! 👀 🖇️Blog: tinyurl.com/mr38wn4y 🖇️Original paper: tinyurl.com/hx2a75jz European Society of Cardiology NEJM #LAAO #Afib Jacopo Imberti Luca Bergamaschi Francesco Vitali Anna Podlasek Liverpool Centre for Cardiovascular Science

🎯 Biomarker-based Age, Biomarkers, Clinical history (ABC)-AF-stroke risk score 🔬26,452 patients with #AFib on DOACs or Warfarin ✅Discrimination of total stroke/SEE was superior compared to others ➡️tinyurl.com/m9xwkyku #ESCStroke #Stroke #ABCAFStroke JACC Journals

✨ Relive the highlights from the 7th #ESCHeartAndStroke Conference: tinyurl.com/4m2vb434 🎉 Don’t miss out on this year’s event in Milan—register now! 🔗 escardio.org/Congresses-Eve… EHJ Editor-in-Chief European Society of Cardiology ESC WG Thrombosis Chairperson Jacopo Imberti Luca Bergamaschi Francesco Vitali

⚠️ MRI-based AI model for the identification of underlying #Afib after ischemic stroke 🔬 brain ischemic lesion pattern on MR images & underlying AF ✅ AUC of 0.94 (95% CI, 0.90–0.98) for AF detection 🖇️ tinyurl.com/23hcdxhn #ESCStroke #AI #whyCMR The Lancet

- 2 days🚨 🔎Register for the latest #ESCStroke webinar! Multimorbidity in stroke risk and management: harnessing novel technologies for risk assessment and management esc365.escardio.org/event/1984?utm… Giulio Francesco Romiti Liverpool Centre for Cardiovascular Science Jacopo Imberti Francesco Vitali Luca Bergamaschi

Hurry up!🚨 The latest #ESCStroke webinar is starting in 2h! Access here👉 tinyurl.com/y58nsyd8 Multimorbidity in stroke risk & management: harnessing novel technologies for risk assessment & management Giulio Francesco Romiti Liverpool Centre for Cardiovascular Science Jacopo Imberti Francesco Vitali

#ESCStrokeBlog out now!🚨 Endovascular treatment of #stroke due to MeVO does not lead to better outcomes than usual care Check out the comment: tinyurl.com/4pbbnj6c & The original article: tinyurl.com/3ap884u7 NEJM European Society of Cardiology

#EHRAtopicweek on new indications for conduction system pacing! Listen to the latest #EHRA_ESC Cardio Talk episode! 🎙️ Join experts Haran Burri & Michael Glikson with Stefan Simović & Jacopo Imberti as they delve into this 🔥topic 🔗bit.ly/3I7s1Vc

Check out the new #EHRA_ESC Cardio Talk, which I co-hosted with Stefan Simović! We discuss the latest ESC consensus document on conduction system pacing with 2 leading experts! Europace Editor-in-Chief European Society of Cardiology 👇👇👇

How can the dissemination of patient-friendly #ESCGuidelines enhance wider implementation, adoption and adherence rate? Prof Lis Neubeck , #ESCPatientForum Chair, is joined by Inge Moelgaard who is sharing her perspective as a Patient Forum and Clinical Practice Guidelines Commitee

Explore the latest in #AFib 💓 and #stroke 🧠 management at the #ESCHeartAndStroke and EuroThrombosis Congress in Milan! Join us as we dive into cutting-edge research 📊 and shape tomorrow’s care 🔬 There is still time to register! 🖇️escardio.org/Congresses-Eve…

In the ASSET-IT trial, early tirofiban ⬆️ excellent functional outcome in pts with acute ischemic #Stroke 👀Full results🖇️tinyurl.com/4y2wt4nn NEJM #ESCStroke

⏱️ Every minute counts In #stroke care, even in the extended window 🆕 CHABLIS-T data showed that delays in tenecteplase treatment (4.5–24h) ⬇️ odds of major reperfusion. tinyurl.com/335574tp Jacopo Imberti Francesco Vitali Luca Bergamaschi European Society of Cardiology #Thrombolysis #CHABLIST

#OPTIMISTmain 👀 Low-intensity monitoring after #thrombolysis may be non-inferior to standard care in low-risk #stroke pts. ⬇️checks, ⬇️burden for nurses 👩‍⚕️& better rest for pts 😴, w/ no compromise on safety! tinyurl.com/mwpyv6m8 Jacopo Imberti Francesco Vitali Luca Bergamaschi

In the #POINT trial, prior statin use was linked to a📉risk of early #stroke recurrence (<7 days). Starting statins after the event did not. ➡️Early prevention starts before the stroke! tinyurl.com/2m5abjep Jacopo Imberti European Society of Cardiology Francesco Vitali Luca Bergamaschi

How do we ensure AI enhances – not replaces – human connection in cardiology? That’s just one of the critical conversations happening at the #ESCAIsummit2025 From AI-powered diagnostics to breakthroughs in 5G, robotics, & virtual care, the Scientific Programme takes you on a

📡 Long-term ICM monitoring after cryptogenic #stroke reveals hidden risks: tinyurl.com/35mk5vw6 🧠1/3 pts developed subclinical AF ⏱️Median detection at ~7 mnts 💊96% started OACs Jacopo Imberti European Society of Cardiology Francesco Vitali Luca Bergamaschi